These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1200 related items for PubMed ID: 17661150
21. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. Feldman AL, Libutti SK, Pingpank JF, Bartlett DL, Beresnev TH, Mavroukakis SM, Steinberg SM, Liewehr DJ, Kleiner DE, Alexander HR. J Clin Oncol; 2003 Dec 15; 21(24):4560-7. PubMed ID: 14673042 [Abstract] [Full Text] [Related]
22. Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer. Bijelic L, Yan TD, Sugarbaker PH. Ann Surg Oncol; 2007 Aug 15; 14(8):2281-8. PubMed ID: 17503156 [Abstract] [Full Text] [Related]
28. Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer. Di Giorgio A, Naticchioni E, Biacchi D, Sibio S, Accarpio F, Rocco M, Tarquini S, Di Seri M, Ciardi A, Montruccoli D, Sammartino P. Cancer; 2008 Jul 15; 113(2):315-25. PubMed ID: 18473354 [Abstract] [Full Text] [Related]
29. Hyperthermic intraperitoneal intraoperative chemotherapy after cytoreductive surgery for the treatment of abdominal sarcomatosis: clinical outcome and prognostic factors in 60 consecutive patients. Rossi CR, Deraco M, De Simone M, Mocellin S, Pilati P, Foletto M, Cavaliere F, Kusamura S, Gronchi A, Lise M. Cancer; 2004 May 01; 100(9):1943-50. PubMed ID: 15112276 [Abstract] [Full Text] [Related]
30. The role of perioperative systemic chemotherapy in diffuse malignant peritoneal mesothelioma patients treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Deraco M, Baratti D, Hutanu I, Bertuli R, Kusamura S. Ann Surg Oncol; 2013 Apr 01; 20(4):1093-100. PubMed ID: 23456386 [Abstract] [Full Text] [Related]
34. Role of explorative laparoscopy to evaluate optimal candidates for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal mesothelioma. Laterza B, Kusamura S, Baratti D, Oliva GD, Deraco M. In Vivo; 2009 Feb 01; 23(1):187-90. PubMed ID: 19368148 [Abstract] [Full Text] [Related]
35. Treatment of microscopic disease with hyperthermic intraoperative intraperitoneal chemotherapy after complete cytoreduction improves disease-free survival in patients with stage IIIC/IV ovarian cancer. Cascales-Campos PA, Gil J, Gil E, Feliciangeli E, González-Gil A, Parrilla JJ, Parrilla P. Ann Surg Oncol; 2014 Jul 01; 21(7):2383-9. PubMed ID: 24599409 [Abstract] [Full Text] [Related]
36. Cytoreductive surgery plus intraperitoneal hyperthermic perfusion is an effective treatment for metastasized malignant mixed mesodermal tumours (MMMT)--report of six cases. Müller H, Nakchbandi V. Eur J Surg Oncol; 2004 Jun 01; 30(5):573-7. PubMed ID: 15135489 [Abstract] [Full Text] [Related]
37. Impact of the peritoneal surface disease severity score on survival in patients with colorectal cancer peritoneal carcinomatosis undergoing complete cytoreduction and hyperthermic intraperitoneal chemotherapy. Chua TC, Morris DL, Esquivel J. Ann Surg Oncol; 2010 May 01; 17(5):1330-6. PubMed ID: 20033321 [Abstract] [Full Text] [Related]
40. Hyperthermic intraperitoneal chemotherapy with oxaliplatin for peritoneal carcinomatosis arising from appendix: preliminary results of a survival analysis. Marcotte E, Sideris L, Drolet P, Mitchell A, Frenette S, Leblanc G, Leclerc YE, Dubé P. Ann Surg Oncol; 2008 Oct 01; 15(10):2701-8. PubMed ID: 18654822 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]